KRISTIAN BRADY: Open Payments
NPI 1679033088 · HAMPSTEAD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 54 payments from 14 companies in 2025. Trend: 2023 $4,448 · 2024 $1,366 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $248 |
| ABBVIE INC. | 14 | $216 |
| Axsome Therapeutics, Inc. | 4 | $171 |
| Lilly USA, LLC | 5 | $93 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Novo Nordisk Inc | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| Amgen Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
Products named: NURTEC ODT, Auvelity, QULIPTA, VRAYLAR, MOUNJARO, Jornay PM, Cologuard Collection Kit, Ozempic.
Industry payments across MD — which companies pay providers there.
